Skip to main content
Atrás
Watch Compare

Pharmagreen Biotech Inc.

Calidad de datos: 83%
PHBI
OTC Utilities Air Transportation
$0.00
$0.00 (0.00%)
Cap. Mercado: 829,615.0
Precio
$0.00
Cap. Mercado
829,615.0
Rango del Día
$0.00 — $0.00
Rango de 52 Semanas
$0.00 — $0.00
Volumen
538,965
Apertura $0.00
Promedio 50D / 200D
$0.00
40.00% below
Promedio 50D / 200D
$0.00
25.00% below

Quick Summary

Puntos Clave

Negative free cash flow of -138,511.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.02
Interest Coverage-18.88

Valoración

PE (TTM)
-1.66
Below sector avg (3.70)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Utilities (448 pares)
Métrica Acción Mediana del Sector
P/E -1.7 3.7
P/B — 1.6
ROE % — 7.9
Net Margin % — 6.8
Rev Growth 5Y % — 4.2
D/E — 1.0

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -500,710.0
ROE N/A ROA -330.17%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138,511.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.02
Interest Coverage -18.88 Asset Turnover N/A
Working Capital -2.12 M Tangible Book Value -2.10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.66 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16.70%
Market Cap 829,615.0 Enterprise Value 829,615.0
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 27.66%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019
Revenue — — — —
Net Income -875,505.0 -4.53 M -2.44 M -767,537.0
EPS (Diluted) — — — —
Gross Profit — — — —
Operating Income -1.10 M -744,064.0 -485,756.0 -645,961.0
EBITDA — — — —
R&D Expenses — — 3,956.0 3,956.0
SG&A Expenses — — — —
D&A — — — —
Interest Expense 28,780.0 680,714.0 298,942.0 —
Income Tax 0.0 0.0 — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019
Total Assets 208,971.0 373,081.0 266,245.0 630,272.0
Total Liabilities 2.03 M 2.07 M 3.20 M 1.46 M
Shareholders' Equity -1.82 M -1.69 M -2.89 M -833,224.0
Total Debt — — 30,028.0 —
Cash & Equivalents — 25,300.0 — —
Current Assets — — 266,245.0 189,177.0
Current Liabilities 1.91 M 2.03 M 3.17 M 1.46 M